Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice-Reference-Cited by-同舟云学术

Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice

Published:2015-08 Issue:35 Volume:290 Page:21591-21602
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Skerrett Rebecca,Pellegrino Mateus P.,Casali Brad T.,Taraboanta Laura,Landreth Gary E.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference70 articles.

1. Decreased clearance of CNS β-amyloid in Alzheimer's disease;Mawuenyega;Science,2010

2. Evidence for impaired amyloid β clearance in Alzheimer's disease;Wildsmith;Alzheimers. Res. Ther,2013

3. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance;Castellano;Sci. Transl. Med,2011

4. Human APOE isoform-dependent effects on brain β-amyloid levels in PDAPP transgenic mice;Bales;J. Neurosci,2009

5. apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain;Deane;J. Clin. Invest,2008

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of Metformin in Alzheimer’s disease: A translational view;Ageing Research Reviews;2024-09

2. Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches;Frontiers in Aging Neuroscience;2024-05-30

3. Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020–2023);Expert Opinion on Therapeutic Patents;2024-02

4. BAC Transgenic Expression of Human TREM2-R47H Remodels Amyloid Plaques but Unable to Reprogram Plaque-associated Microglial Reactivity in 5xFAD Mice;2023-08-07

5. Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease;Current Molecular Pharmacology;2023-06